Vertex Pharmaceuticals (VRTX ... their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside ...

However, this doesn't mean you can't have strong opinions about certain investments. I'm quite confident that some stocks will be winners over the long run. Here are my three highest-conviction growth ...

Vertex Pharmaceuticals (VRTX ... From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6 ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

Cannabix Technologies Inc. (the "Company" or "Cannabix") developer of marijuana and alcohol breath testing devices is pleased to report that it has made significant updates to its Cannabix Marijuana ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other stocks that will make you rich in 2025. Jurrien Timmer, Director of ...

Hardman Johnston Global Equity highlighted stocks like Vertex Pharmaceuticals Incorporated ... These stocks are handpicked by our research director, Dr. Inan Dogan. • Ad-Free Browsing: Enjoy ...

- In head-to-head clinical trials, ALYFTREK was non-inferior on ppFEV 1 and further decreased sweat chloride compared to TRIKAFTA ® - BOSTON, December 20, 2024--(BUSINESS WIRE)--Vertex ...

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX ... Keating, M.D., Co-Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program at Columbia University and investigator in the ALYFTREK ...

When the plan is enacted, the term of the current members of Vertex’s board of directors will expire, and a new board will be appointed. However, it is possible current directors could be ...

Vertex Pharmaceuticals Incorporated (Nasdaq ... for the treatment of CF,” said Claire L. Keating, M.D., Co-Director of the Gunnar Esiason Adult Cystic Fibrosis and Lung Program at Columbia ...

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors ... American Express, and Vertex Pharmaceuticals. The Motley Fool ...